Institution
Fudan University Shanghai Cancer Center
Recent research
- BiologyOpen access
Gastric cancer (GC), a leading global malignancy, urgently requires the discovery of novel diagnostic and therapeutic targets. The roles of extracellular vesicle (EV)- derived circular RNAs (circRNAs) as diagnostic biomarkers and functional regulators, particularly in vascular re...
- Health & MedicineOpen access
Nebulized lidocaine for preventing postoperative pulmonary complications in major abdominal surgery
Despite the lung-protective ventilation strategy, high incidence of postoperative pulmonary complications (PPCs) after major non-cardiac surgery remains a major concern in the perioperative care due to high morbidity and mortality. The study aimed to evaluate the efficacy and saf...
- Health & Medicine
Evaluation of 68Ga Labeling Strategies and Thermostability of HER2-Targeted Nanobody NB46
Abstract The HER2-targeted nanobody NB46 was evaluated for labeling strategy flexibility and thermostability. Random and site-specific 68Ga labeling strategies were compared. Both conjugates exhibited high HER2 affinity, comparable to unmodified NB46. Cellular uptake, pharmacokin...
- Health & MedicineOpen access
Trastuzumab deruxtecan (T-DXd) is an antibody-drug conjugate (ADC) approved for HER2-low metastatic breast cancer (mBC), showing improved survival outcomes in clinical trials. However, real-world evidence on its effectiveness among Chinese patients remains limited. Patients with...
- Health & MedicineOpen access
Neoadjuvant chemotherapy (NAC) for colorectal cancer liver metastasis (CRLM) remains a major clinical challenge, with outcomes varying widely among patients, yet the mechanisms that drive therapeutic resistance remain incompletely understood. In this study, we integrated single‑c...
- Health & MedicineOpen access
ABSTRACT Acquired resistance to temozolomide (TMZ) remains a major therapeutic challenge in glioblastoma (GBM), with metabolic reprogramming emerging as a critical driver of treatment failure. Procollagen lysyl hydroxylase 1 (PLOD1) is identified as a key regulator of adaptive me...
- BiologyOpen access
ABSTRACT Limited aqueous dispersibility and potential off‐target toxicity hinder the development and clinical translation of proteolysis‐targeting chimeras (PROTACs). Herein, a bioactive self‐delivering “Split Nano‐Assembly of Photosensitizers and Targeting Chimeras” (SNAP‐TAC) t...
- Health & MedicineOpen access
Abstract This prospective, randomized, single-blinded, phase II trial evaluated whether large language model (LLM)-assisted preoperative communication, compared with standard communication, reduces patient anxiety and improves illness perception and satisfaction while decreasing...
- Health & MedicineOpen access
Distinct Molecular Landscape and Clinical Subtype of HPV-Positive Esophageal Squamous Cell Carcinoma
Background: This study aimed to investigate the prevalence of human papillomavirus (HPV) infection in Chinese patients with esophageal squamous cell carcinoma (ESCC) and its association with driver gene mutations (EGFR, KRAS, PIK3CA, PTEN), clinicopathological features, and progn...
- BiologyOpen access
Eggerthella lenta disrupts the gut vascular barrier to drive colorectal cancer liver metastasis
Distant metastasis is the leading cause of death in colorectal cancer (CRC), and the gut vascular barrier (GVB) is the first obstacle to hematogenous spread. To investigate whether GVB function is directly influenced by metastasis-associated bacteria, we analyzed two cohorts comp...
- BiologyOpen access
The Regulator of Cullins 1 (ROC1) or RING box protein-1 (RBX1) is an essential component of the largest multiunit Cullin-RING ubiquitin ligase (CRL). Previous studies demonstrated that ROC1 is frequently overexpressed in multiple malignancies, which predicts advanced cancer stage...
- Health & MedicineOpen access
Association between serum cotinine levels and prostate-related clinical endpoints
Abstract Purpose This study examined the association between serum cotinine, an objective biomarker of tobacco exposure, and prostate-related clinical endpoints in men participating in the National Health and Nutrition Examination Survey. Methods Cross-sectional data from five NH...
- Health & MedicineOpen access
This is a summary of a research article reporting the findings of the HER2CLIMB-05 trial (NCT05132582), a randomized, double-blind, placebo-controlled, international, phase III trial. The HER2CLIMB-05 trial was conducted to compare the efficacy and safety of adding tucatinib vers...
- Health & MedicineOpen access
Abstract The formation of Candida albicans biofilms is a key factor contributing to clinical antifungal treatment failure and multidrug resistance (MDR). Overcoming biofilm formation is an urgent priority in antifungal therapy. Here, we report a synergistic strategy utilizing far...
- BiologyOpen access
Abstract Despite improved survival rates with dual trastuzumab and pertuzumab therapy, patients with HER2-positive breast cancer frequently experience disease progression due to intrinsic or acquired resistance. Elucidating the underlying mechanisms of resistance and identifying...
- BiologyOpen access
Ipsilateral breast tumor recurrence (IBTR) presents a critical clinical challenge, as it is strongly associated with a high risk of subsequent distant metastasis, the primary cause of mortality. Although the spatial organization of the tumor microenvironment (TME) may contribute...
- Engineering & TechnologyOpen access
Abstract Pancreatic cancer faces the challenges of tumor progression and postoperative pancreatic fistula during the perioperative period, which severely affect patient prognosis. In this study, an injectable self-healing multifunctional hydrogel (CMCGel) was developed based on d...
- BiologyOpen access
Background Pancreatic ductal adenocarcinoma (PDAC) lacks biomarkers for accurate diagnosis and prognostic stratification. The standard, CA19-9, has suboptimal specificity in differentiating PDAC from mimics like chronic pancreatitis (CP). We investigated serum metabolomic signatu...
- Health & MedicineOpen access
Anti-cancer drug clinical research
Abstract Malignant tumors are major diseases that seriously threaten human health, and the unmet clinical demand for treatments in the field of oncology has been persistently large. The research and development of new antineoplastic drugs has become a powerful means to address th...
- Health & MedicineOpen access
Neoadjuvant Anbenitamab and HB1801 in ERBB2 -Positive Breast Cancer
IMPORTANCE The combination of neoadjuvant taxanes with trastuzumab and pertuzumab remains the cornerstone treatment strategy in ERBB2 -positive breast cancer. Anbenitamab (a ERBB2 -biparatopic antibody that induces profound receptor clustering) and HB1801 (a solvent-free albumin-...